Lightship, a clinical research solutions provider and Acclinate, a digital health company, are collaborating to increase access and engagement of diverse participants in a decentralized neurology clinical trial for a large pharmaceutical company.
Today, we announced our partnership with Lightship®, a leading virtual-first and hybrid provider of clinical research solutions. As partners, we will collaborate on solutions to increase access to clinical trials and engagement of diverse populations and communities of color.
"Underrepresented racial and ethnic populations have been profoundly impacted by inequities in the healthcare system," says Delmonize "Del" Smith, PhD, Co-Founder and CEO of Acclinate. "While people of color make up over 42 percent of the U.S. population, they are significantly underrepresented in clinical research, leading to even greater healthcare disparities. Our #NOWINCLUDED™ community educates, engages, and empowers communities of color to make informed decisions about their health, including opportunities to take part in clinical trials. Combined with our e-DICT™ predictive analytics tool, we help pharmaceutical companies and other health organizations present their clinical trials to diverse members who are most likely to participate."
To read more about the partnership, check out the press release here.